Summary Background Understanding the burden of atrial fibrillation (AF) and oral anticoagulant (OAC) use in patients with chronic obstructive pulmonary disease (COPD) is important for stroke prevention in this high-risk population. We assessed trends in AF incidence and OAC initiation among patients with COPD in UK pri...
Brianna Murray, S. Beradid, Pierre Ernst et al.· EClinicalMedicine· 0 citations
OBJECTIVES
Many observational studies of influenza vaccine effectiveness have faced issues of residual confounding and immortal time bias. We aimed to assess the effectiveness in people with COPD, using a novel study design to address these methodological challenges.
METHODS
We conducted a cohort study emulating a ra...
S. Galmiche, S. Dell'Aniello, L. Lévesque et al.· Clinical Microbiology and In...· 0 citations
RATIONALE
Obstructive sleep apnea (OSA) is highly prevalent in type 2 diabetes (T2D), sharing metabolic risk factors, notably obesity, and increased cardiovascular outcomes. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been shown to reduce OSA severity in clinical trials but their role in preventing incide...
Charles Khouri, S. Dell'Aniello, C. Jambon-Barbara et al.· American Journal of Respirat...· 0 citations
BACKGROUND
While beta-blockers are effective at reducing mortality in certain cardiovascular diseases (CVD), their effectiveness in patients with chronic obstructive pulmonary disease (COPD) and CVD is uncertain, particularly with the concurrent use of long-acting β2-agonist bronchodilators (LABA).
RESEARCH QUESTION...
S. Suissa, S. Dell'Aniello, C. Renoux et al.· Chest· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
